Table 2.
Disease | Deaths, thousands | YLL, millions | DALYs, millions | Sickday severity |
---|---|---|---|---|
I. Strong evidence | ||||
ARI* (880,000) | 270–400 | 9.2–14 | 9.6–14 | 0.28 |
COPD† (60,000) | 20–35 | 0.19–0.34 | 0.39–0.68 | 0.43 |
Lung cancer† (6,000) | 0.42–0.79 | 0.0046–0.0086 | 0.0048–0.0090 | 0.15 |
II. Moderate evidence | ||||
Blindness† (∼0) | ≈0 | ≈0 | 0.064–0.13 | 0.5 |
TB† (250,000) | 53–130 | 0.97–2.4 | 1.1–2.6 | 0.15 |
APO (560,000) | ? | ? | ? | |
Asthma (20,000) | 3.6–9.0 | 0.046–0.12 | 0.27–0.68 | 0.15 |
III. Suggestive evidence | ||||
IHD† (1,100,000) | 54–200 | 0.49–1.8 | 0.55–2.1 | 0.32 |
Possible total (2,300,000) | 400–780 | 11–18 | 12–20 | |
Range used§: | 400–550 | 11–16 | 12–17 |
Estimates listed in order of the strength of evidence under Indian conditions. Mortality and conversion to life years lost and morbidity as in ref. 37. APO, adverse pregnancy outcomes. Severity is taken as the disability weighting in ref. 37 and varies from 0 (healthy) to 0.85 (severe disability). Indian total deaths for each disease are listed in parentheses.
Under 5 years only.
Women only.
Disability-adjusted life year = (years lost to premature death) + (years lost to disability) ∗ (severity factor) (37).
Full range for Class I plus low end of ranges for Classes II and III.